HAMLET Pharma releases further data from clinical study

Booking.com

At the end of July 2019, Hamlet Pharma announced the successful completion of the Phase I/II bladder cancer study. We now provide more detailed information about the study outcome.
At the end of July 2019, Hamlet Pharma announced the successful completion of the Phase I/II bladder cancer study. We now provide more detailed information about the study outcome. 

Twenty patients were treated with Alpha1H and patients received 6 instillations during one month, followed by surgery to remove the tumor. A further visit was included to document the safety of Alpha1H. Another 20 patients received

Booking.com

Source: HAMLET Pharma releases further data from clinical study

Booking.com

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.